Skip to Content

Koninklijke DSM NV DSM

Rating as of

Morningstar’s Analysis

Valuation
Currency in EUR
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

DSM Is an Exemplary Capital Allocator

Rob Hales, CFA Equity Analyst

Analyst Note

| Rob Hales, CFA |

We award no-moat DSM an Exemplary capital allocation rating based on our assessments of the balance sheet, investment, and shareholder distributions. The balance sheet is sound. DSM has medium business risk, but debt levels are very low and the maturity schedule is balanced.

Read Full Analysis

Company Profile

Business Description

Royal DSM is a Dutch company focused on life sciences and materials science. Key business segments include nutrition and materials. Major products are vitamins in nutrition and engineering plastics and resins in performance materials. About 35% of sales are generated in Europe. North America and China are also important markets for the company.

Contact
Het Overloon 1, P.O. Box 6500
Heerlen, LI, 6411 TE, Netherlands
T +31 455788111
Sector Basic Materials
Industry Specialty Chemicals
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2021
Stock Type
Employees 21,173